Introduction
Ampli®cation with subsequent overexpression of Nmyc in neuroblastomas is associated with rapid disease progression and poor clinical outcome Seeger et al., 1985 ; for a recent review see Schwab et al., 1995) . N-myc can be expressed at high level in neuroblastomas without ampli®cation, but the clinical signi®cance of strong N-myc expression in such tumors is not clear (Slavc et al., 1990; Hiyama et al., 1991) . Enhanced expression of N-myc induces human neuroblastoma cells to grow in soft agar and in nude mice (Schweigerer et al., 1990) and accelerates S-phase entry of quiescent cells after serum stimulation (Lutz et al., 1996) .
Little is known about the regulation of N-myc expression in neuroblastomas. Basal promoter activity has been assigned to 200 base pairs immediately upstream of a region with multiple transcription start sites (Hiller et al., 1991; Wada et al., 1992) . In addition, an enhancer has been mapped 1 kb further upstream (Hiller et al., 1991; Imamura et al., 1992) , and a tissue-speci®c silencer resides within the ®rst intron (Woodru et al., 1995) . Studies with transgenic mice suggest that 3 kb¯anking sequences both upstream and downstream of the coding region contain all cis-elements necessary for proper developmental expression of N-myc (Zimmerman et al., 1990) . Both all-trans retinoic acid and NGF down-regulate Nmyc expression concomitant with induction of terminal dierentiation and are the only signaling molecules known to in¯uence N-myc expression in neuroblastoma cells (Thiele et al., 1985; Wada et al., 1992; Matsushima et al., 1993) . The ability of retinoic acid and NGF to down-regulate the expression of ampli®ed N-myc suggests that these multiple gene copies are not necessarily deregulated (Thiele et al., 1985; Matsushima et al., 1993) . In the developing mouse brain and in precursor B lymphocytes N-myc expression is not only controlled at the level of transcriptional initiation but also at the level of transcriptional elongation (Xu et al., 1991; Morrow et al., 1992) . Deletion of sequences from the non coding exon 1 of murine N-myc, which results in loss of transcriptional attenuation by an as yet unidenti®ed mechanism, increases the oncogenic potential of N-myc in the rat embryo ®broblast cotransformation assay compared to N-myc constructs with intact attenuation (Xu et al., 1995) . However, no data exist to support a role for transcriptional attenuation in the regulation of N-myc expression in neuroblastomas, and overexpression of N-myc in smallcell lung cancers does not involve changes in transcriptional attenuation (Krystal et al., 1988) .
The 200 bp basal promoter is to 94% conserved between the N-myc genes of mouse and man and contains several potential transcription factor binding sites, including E2F-sites and GC-boxes (Ibson and Rabbits, 1988) . DNA-protein interactions in this region are involved in the down-regulation of N-myc during both maturation of B-lymphocytes (Smith et al., 1992) and terminal dierentiation of embryonal carcinoma cells (Hara et al., 1993) , but none of these sites has been analysed in neuroblastoma cells.
We have analysed the 200 bp basal promoter in human neuroblastoma cells using a combination of transient reporter gene assays, DMS-in vivo-footprinting, and electrophoretic mobility shift assays. While in transient assays the basal promoter activated reporter gene expression in all cell lines analysed regardless of N-myc expression examination of the endogenous promoter revealed several changes of promoter architecture that are correlated with N-myc expression. These changes are clustered in a 50 bp region and include (1) protein binding to two overlapping E2F-sites, (2) extreme hypersensitivity of guanine 7159 probably as a result of protein binding to a neighbouring evolutionary conserved sequence and (3) a short stretch of single stranded DNA accompanied by a single protected guanine.
Results

Mutational analysis of the N-myc basal promoter
To identify regulatory elements involved in N-myc regulation we cloned the 200 bp sequence encompassing the basal promoter (7221 to +21) in front of a luciferase reporter and then introduced clustered point mutations into potential regulatory sites ( Figure 1a ) that were selected for one of two reasons: (a) they represent known transcription factor binding sites: the ®rst are two overlapping E2F-sites in inverted orientation (here referred to collectively as 5'E2F; 7180 to 7169); the second is an E2F-site located immediately downstream (3'E2F; 7165 to 7159); the third were two GC-boxes (7130 to 7125 for GCbox2; 763 to 758 for GC-box1), possible binding sites for transcription factors of the Sp1 family; (b) they are evolutionary conserved between humans, mice, and chickens and are therefore candidates for regulatory elements: two such conserved regions, CR1 (7145 to 7135) and CR2 (757 to 743) are present ( Figure 1b) . CR1 is an octamer binding site in seven out of eight positions and has an adenine at position 10 which is a frequently found extension of the octamer motif (Falkner and Zachau, 1984) .
The reporter constructs with either the wild-type sequence or the various point mutations were transiently transfected into a panel of human neuroblastoma cell lines with strong (Nb-1, Kelly, and Nb-12) or with very low endogenous expression of N-myc (SH-EP) and into HeLa cells, which do not express N-myc. The wildtype construct pNmyc activated transcription of the a b Figure 1 (a) Sequence of the promoter fragment of the human N-myc gene used in this study. Boxed sequences show potential regulatory elements (see text for details). The bent arrows mark the positions of the multiple transcription start sites . The horizontal arrow indicates the position of primer set BX used for in vivo-footprint analysis of the coding strand. Primer set B for the analysis of the non coding strand anneals further upstream around position 7275. (b) Sequence alignment of the basal promoters of the human (Stanton et al., 1986) , mouse (DePinho et al., 1986), and chicken (Sawai et al., 1990 ) N-myc genes Figure 2 ). Therefore, the 5'E2F-site can both activate and repress transcription, and overexpression of N-myc from the ampli®ed gene copies in Nb-12 does not result from promoter activation by the 5'E2F-site, but is rather achieved in spite of the repressive eect of this element. Mutation of the 3' E2F-site did not in¯uence reporter gene expression with the exception of Nb-1, in which promoter activity was reduced to 60% of the wild type. Mutations in both CR1 and CR2 decreased reporter gene activity to 80 to 50% of wild-type activity in some cell lines (e.g. Nb-1) while in others (e.g. Nb-12) an eect was not seen (Figure 2 ). Mutation of either one of the two GC-boxes decreased reporter gene activity to 55 ± 75% in all cell lines except for Kelly cells where mutation of the more proximal GC-box had no eect.
To establish whether an E2F transcription factor is responsible for the E2F-site dependent activation and repression, respectively, pNmyc was co-transfected with an expression construct for DP1, a heterodimerization partner of E2F which is essential for DNA binding (for a review see La , and expression constructs for either E2F-1, E2F-3, and E2F-4 into Kelly cells. Enforced expression of E2F-3 activated reporter gene expression sixfold while E2F-1 and E2F-4 had no eect (data not shown).
In vivo protein binding to the basal promoter correlates with N-myc expression and is similar at ampli®ed and single copy N-myc To identify DNA-protein interactions at the N-myc basal promoter in living cells we used DNA-in vivofootprinting, which visualizes interactions of proteins with guanines in the major groove of the DNA double helix, employing the primer sets indicated in Figure 1a . Analysis of the non coding strand revealed partial protection of two guanines of the 5'E2F-site accompanied by weak hypersensitivity of two¯anking guanines in Nb-1 and Nb-12 with strong N-myc expression, but not in SH-EP with barely detectable N-myc expression, suggesting a role of the 5'E2F-site in the expression of N-myc in vivo (Figure 3a ). An additional guanine further upstream in CR1 at position 7135 was protected in Nb-1 and Nb-12.
The coding strand revealed strong hypersensitivity of a guanine at position 7159 in all cell lines with endogenous N-myc expression (Figure 3b ; compare to the more typical hypersensitivity at the guanines anking the 5'E2F-site in Figure 3a ), but not in GI-M-EN, HeLa, and control DNAs from GI-M-EN and Nb-12 modi®ed by DMS in vitro, suggesting that hypersensitivity at this site is correlated with N-myc expression. In line with this, the 7159 guanine was less hypersensitive in SH-EP cells with low N-myc expression. In the non coding strand three consecutive guanines downstream of the hypersensitive guanine were partially protected from modi®cation by DMS suggesting that binding of a protein at this site may be responsible for the hypersensitivity at 7159 (Figure 3a ; visible in shorter exposures, data not shown). Starting from the hypersensitive 7159 guanine, which we In vivo regulation of N-myc expression W Lutz and M Schwab assume to de®ne one border of the DNA-protein interaction, the sequence that extents to the weakly protected guanines reads 5'-CCTCCC-3' on the coding strand and is hereafter referred to as CT-box. Beside the hypersensitive guanine at 7159 another guanine at 7140, which is part of CR1, also showed enhanced sensitivity in N-myc expressing cell lines.
Guanine 7140 occupies the central position of a 5'GGA 3' triplet. This sequence consistently yields an underreacted middle guanine in the reaction with DMS in double stranded DNA but not in single stranded DNA (Ephrussi et al., 1985) . Reduced sensitivity of guanine 7140 relative to guanine 7141 is seen in DNA from GI-M-EN, SH-EP and HeLa and in There was no evidence of protein binding to the GCbox2 (Figure 3b ). The analysis of both strands of GCbox1 and CR2 with additional primer sets did not identify any hypersensitive or protected residues (data not shown). In summary, the DMS in vivo-footprinting identi®ed three major changes in the basal promoter that accompany N-myc transcription ( Figure 3c ). These changes are gathered in a 50 bp region and include: (1) Occupation of the 5' E2F-site; (2) Hypersensitivity at 7159 and weak protection of three consecutive guanines probably as the result of protein binding to a neighbouring CT-box; (3) Presence of at least part of CR1 as single stranded DNA accompanied by a single protected guanine. We conclude that the basal promoter contributes to the cell type-speci®city of Nmyc expression in vivo despite the lack of correlation between reporter gene activation in transient assays with endogenous N-myc expression.
Although an additive eect would explain the high expression levels of ampli®ed genes, there is no experimental support for the recruitment of all copies of an ampli®ed gene for transcription. All transcriptionally active gene copies can be expected to be engaged in the same DNA-protein interactions and only if protein binds at all or at least the vast majority of gene copies the guanines in cells with N-myc ampli®cation will be protected. Therefore, the nearly complete protection of guanines in Nb-12 with approximately 50 copies of N-myc demonstrates occupation of the 5' E2F-site of the majority of the ampli®ed N-myc genes in vivo (Figure 3a ). In line with this, the autoradiographic signal for the 7159 guanine is equally strong in N-myc expressing cell lines with and without N-myc ampli®cation demonstrating hypersensitivity of this guanine in all ampli®ed copies of N-myc (for the underlying theoretical considerations see Materials and methods).
We conclude that both the 5' E2F-site and the CTbox of all copies of ampli®ed N-myc are engaged in the same DNA-protein interactions consistent with the idea that all gene copies contribute to N-myc expression in cell lines with ampli®cation.
Nuclear extracts contain a zinc-requiring CT-box binding protein
To obtain independent evidence for an involvement of the CT-box in the regulation of N-myc expression we analysed nuclear extracts from dierent cell lines for the presence of a CT-box binding protein. Electrophoretic mobility shift assays with a 36 bp 32 P-labeled CT-box probe revealed several retarded bands the slowest migrating one (hereafter referred to as shift A) being speci®c for the wild-type CT-box, because it was not produced by a mutant version of the CT-box, CTmut (CCTCCC?CCTAAA) and because a 100-fold molar excess of unlabeled CT-box successfully competed for binding, while CTmut or an unrelated competitor did not (data not shown). Expression of the CT-box binding protein was not restricted to neuroblastoma cells because shift A was produced with nuclear extracts of both neuroblastoma cells and HeLa cells (data not shown).
To de®ne the sequence requirements for the shift A, dierent mutated CT-box-probes were tested for their ability to compete at 100-fold molar excess with the radiolabeled wild type CT-box for binding (Figure 4) . Alterations CCTCCC?AATCCC or CCTAAA completely abolished competition. Substitution of the central T by an A resulted in partial competition, whereas substitution by a G, which generates a GC-box consensus sequence, competed equally eective as wild type probe. Mutations at residues¯anking the cytosines (mut1 and mut5) as well as mutations farther away (mut00 and mut6) with the exception of mut0 competed less eectively than wild-type CT-box probe suggesting a minor role of these¯anking sequences in protein binding.
To further evaluate the sequence requirements of the CT-box we used an ME1a1-probe derived from the cmyc promoter as a competitor, which shares the 5'-CCTCCC-3' sequence with the CT-box-probe but has no homology in the¯anking sequences (Asselin et al., 1989; Hall, 1990; Bossone et al., 1992; Figure 4b ). Since the ME1a1-probe competed eectively with the CT-box-probe the sequence 5'-CCTCCC-3' constitutes the core protein binding site (data not shown). This sequence is conserved in the N-myc promoter of man, mouse and chicken supporting an evolutionary conserved role of this element in N-myc regulation (Figure 1b) .
Several proteins are known to bind the ME1a1-site in vitro. Among these is a zinc-®nger protein, MAZ, also referred to as ZF87 (Bossone et al., 1992; Pyrc et al., 1992) . We therefore tested, whether the protein responsible for shift A requires Zn 2+ for binding to DNA. Increasing amounts of the Zn 2+ -speci®c chelator 1,10-orthophenanthroline interfered with complex formation, and this eect could be reversed by the addition of increasing amounts of Zn 2+ ( Figure 5 ). Therefore, protein binding to the CT-box requires Zn
2+
. Preliminary results of supershift assays with a monoclonal antibody that speci®cally recognizes MAZ (a kind gift of KB Marcu) indicate that the CT-box binding protein is not MAZ (data not shown).
In addition to ME1a1 the c-myc gene contains an array of ®ve elements upstream of P1 that are identical in sequence to the CT-box of N-myc (DesJardins and Hay, 1993) . These CT-elements bind two sequencespeci®c single-stranded DNA-binding proteins, hnRNP K and CNBP, the latter requiring Zn 2+ (Takimoto et al., 1993; Michelotti et al., 1995) . Since a 100-fold molar excess of either of the single strands of the CTbox did not compete with the double stranded CT-box for binding of the protein that produces shift A we conclude that neither CNBP nor hnRNP K are responsible for shift A (data not shown).
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Multiple copies of the CT-box activate an N-myc derived minimal promoter
To analyse if the CT-box activates a linked promoter we cloned four copies of the CT-box in front of an Nmyc derived minimal promoter (760 to +18) attached to a luciferase gene. Constructs were transiently transfected into several neuroblastoma cell lines and into HeLa cells, and luciferase activity was determined. The minimal promoter by itself did not substantially activate reporter gene expression compared to the promoterless control vector pGL-3-Basic in any cell line ( Figure 6 ). Four copies of the CT-box increased promoter activity in all cell lines ranging from 3.5-fold CT-box dependent activation was strong in cell lines without detectable or with low endogenous expression of N-myc, and weak in all lines with high expression regardless of N-myc copy number. We therefore tested whether the N-Myc protein may negatively regulate the N-myc minimal promoter through the CT-box by cotransfecting a CMV-N-myc expression vector and the reporter construct containing four CT-boxes attached to the minimal promoter into Kelly and SH-EP. Enforced expression of N-myc did not reduce luciferase activity, suggesting that N-myc expression is not negatively autoregulated through the CT-box (data not shown).
To test intransient assays the activity of the CT-box within the environment of the basal N-myc promoter (7200 to +18) we compared the activity of the wild type construct (pNmyc) with that of a CT-box mutant (pCTmut, CCTCCC?CCTAAA). Luciferase activity was not decreased after mutation of the CT-box suggesting that the single CT-box does not activate transcription in transient assays (data not shown).
There are various possibilities to explain the lack of activity of the wild type CT-box within the environment of the basal N-myc promoter, one being that the CT-box might not act as an enhancer but as an antisilencer (Frenkel et al., 1994) . In this case the activity of the CT-box would only be evident in the presence of the corresponding silencer. To test whether the CT-box is an antisilencer additional N-mycsequences downstream of the 200 bp promoter including all of intron 1 containing a silencer (Woodru et al., 1995) were inserted into constructs pNmyc and pCTmut and transiently assayed. Thesë -speci®c chelator. A gel with a lower degree of crosslinking compared to the gel in (a) was used in this experiment. The intensity of the fastest migrating band varies from experiment to experiment probably with the age of the nuclear extract used Figure 6 Multiple copies of the CT-box linked to an N-myc minimal promoter activate transcription of a reporter gene in transient assays. The indicated luciferase reporter constructs were co-transfected with a b-galactosidase expression vector using DOTAP. Thirty six hours after transfection cells were lysed and enzyme activities measured. Each transfection was done in triplicate and repeated at least twice. The numbers given derive from one representative experiment
In vivo regulation of N-myc expression W Lutz and M Schwab additional sequences reduced reporter gene activity three to ®vefold compared to the shorter constructs. However, no dierences were observed between the wild-type and the CT-box-mutant (data not shown). We conclude that the CT-box is not an antisilencer of the N-myc downstream silencer. Other explanations for the lack of an eect of the CT-box on reporter gene expression in transient assays would be the absence of distal elements cooperating with the CT-box, or the lack of an appropriate chromatin environment.
Discussion
As a ®rst step towards understanding the mechanistic basis of N-myc expression in neuroblastomas we have identi®ed several elements in the basal promoter, an E2F-site, a CT-box and the single stranded CR1 that contribute to N-myc regulation in vivo. All these elements are gathered in a 50 bp sequence that is dierently arranged in vivo in N-myc expressing versus non expressing cells indicating that the basal promoter provides cell type speci®city to the N-myc promoter although this is not evident from transient assays.
Role of the E2F-site in N-myc expression
As shown by transient assays and footprinting the 5'E2F-site mediates control of N-myc expression in vitro and in vivo suggesting that members of the E2F/ DP-family of transcription factors regulate N-myc in neuroblastomas. Disruption of the 5'E2F-site decreased reporter gene expression in Kelly and Nb-1, and ectopically expressed E2F-3 activated reporter gene expression indicating that the 5'E2F-site can recruit transcriptional activators. The loss of protein binding to the 5'E2F-site concomitant with down-regulation of N-myc during dierentiation of human embryonal carcinoma cells would be in line with an activating function of the 5'E2F-site (Hara et al., 1993) . However, negative regulation of promoter activity by the 5'E2F-site in Nb-12 with ampli®cation of N-myc and in SH-EP with single copy N-myc demonstrates that the 5'E2F-site can also mediate transcriptional repression. This suggests that the 5'E2F-site may be atypical in that it is able to both activate and repress transcription depending on the repertoire of dierent transcription factors expressed in individual cellular settings. It is tempting to speculate that the physiological role of the 5'E2F-site is to mediate down-regulation of N-myc during dierentiation. In this case, Kelly and Nb-1 would represent tumor lines with a reprogrammed E2F-site that activates rather than represses transcription as a consequence of overexpression of an E2F-family member, as recently suggested for the E2F-site of B-myb . In any case, transient assays do not faithfully re¯ect regulatory events at endogenous E2F-sites (DeGregori et al., 1995) and, therefore, additional experiments are required to clarify the role of the 5'E2F-site in neuroblastoma cells.
Role of the CT-box in N-myc expression
The transiently transfected 200 bp basal promoter activated reporter gene expression in all cell lines tested regardless of endogenous N-myc expression. In contrast, guanine 7159 was hypersensitive only in Nmyc expressing cell lines suggesting that ± although not evident in transient assays ± the basal promoter controls cell type-speci®c expression of N-myc in vivo. A role of the neighbouring CT-box in N-myc regulation is supported by the binding of a protein from neuroblastoma nuclear extracts to the CT-box and by reporter gene assays demonstrating the ability of multiple CT-boxes to activate a linked N-myc minimal promoter. The single CT-box in the native N-myc promoter ± in contrast to multiple CT-boxes in front of a minimal promoter ± did not activate transcription suggesting a requirement for multiple CT-boxes to achieve transcriptional activation in transient assays (for a discussion see Tanaka, 1996) .
There are several explanations why a single CT-box in the context of it's native promoter does not activate reporter gene expression in transient assays: (1) the severe local disruption of DNA topology represented by the hypersensitive guanine 7159 suggests that regulation through the CT-box may involve changes in chromatin structure and that, therefore, activation of transcription will not be possible on non chromatin templates (for a review see Kingston et al., 1996) . For instance, the MED-1 element of the P-glycoprotein gene is only functional after stable integration but not when transiently assayed (Ince and Scotto, 1996) ; (2) essential long range interactions of the CT-box with distal regulatory elements outside the 200 bp sequence may be missing in the reporter constructs; (3) activity of the CT-box may be restricted to a small period during the cell cycle. In this case, CT-box-dependent activation would be masked in asynchronously growing cell populations as was recently reported for an E2F-site that activates the cyclin E promoter speci®cally during a small time window late in G1 (Botz et al., 1996) .
All copies of N-myc are equally active in neuroblastoma cells with ampli®cation
Gene ampli®cation is a frequent mechanism of oncogene activation in tumors and is generally accompanied by overexpression (for a review see Amler and Schwab, 1990) . Although this overexpression may result from an additive expression eect of the ampli®ed gene, mRNA synthesis at all gene copies to our knowledge has not been demonstrated experimentally. In vivo-footprinting of the ampli®ed N-myc shows that all gene copies show both protein binding to the 5'E2F-site and hypersensitivity at the 7159 guanine consistent with all ampli®ed gene copies being recruited for transcription.
An increased sensitivity to the extent seen at the 7159 guanine has only rarely been described (Hornstra and Yang, 1992; Rein et al., 1994) and reveals a major distortion of local DNA structure. This is supported by the presence of DNA in single stranded conformation in the neighbouring CR1 element. The weaker hypersensitivity of guanine 7159 accompanied by lack of hypersensitivity of guanine 7140 in SH-EP with very low expression of N-myc (Breit and Schwab, 1989) indicates a distinct structural state of the DNA in the vicinity of the CT-box either because of binding of a dierent protein or because the CT-box binds a multiprotein complex that is only partially assembled
In vivo regulation of N-myc expression W Lutz and M Schwab in SH-EP. In the latter case SH-EP would retain the Nmyc gene in an easily accessible`standby'-position that may be a prerequisite for the spontaneous transdifferentiation of epithelial-like SH-EP cells with low N-myc expression into cells with a more neuron-like morphology with higher N-myc expression (Sadee et al., 1987) .
The CT-box represents a frequently used regulatory element interacting with proteins that require Zn 2+ for DNA-binding
The CT-box 5'-CCTCCC-3' is present in many mammalian genes, and some of these CT-boxes have been shown to control gene expression (Table 1; included are only genes where the CT-box sequence was de®ned as the protein binding site by footprinting or methylation interference assays; analysis of additional mammalian promoters by mobility shift assays and reporter gene assays suggest, however, that the list of genes with functional CT-boxes is considerably longer). The majority of CT-box binding proteins characterized so far either contain zinc-®nger motifs or require zinc for DNA binding (Table 1) . A number of zinc-®nger proteins is known to cause a local disruption of DNA structure by either bending DNA (Natesan and Gilman, 1993) or by inducing DNA unwinding (Shi and Berg, 1996) , oering a potential explanation for the hypersensitivity of guanine 7159. In some promoters zinc ®nger proteins perform a purely architectural function and therefore will not in¯uence gene expression in transient assays (Natesan and Gilman, 1993) . Recently, a novel zinc ®nger protein that binds the CT-boxes of two type I collagen genes was described and found not to in¯uence expression of the corresponding CT-box controlled reporter construct in transient assays (Hasegawa et al., 1997) .
Two CT-boxes mediate retinoic acid-controlled expression of the oct3/4 gene in embryonal carcinoma cells (Minucci et al., 1996) . Since the N-myc promoter does not contain known retinoic acid responsive elements (Wada et al., 1992) , the CT-box may mediate the N-myc down-regulation observed in neuroblastoma cells that have been induced to dierentiate by treatment with retinoic acid (Wada et al., 1992) .
The CT-box is identical to the consensus GC-box except for the central thymine. The two boxes may functionally overlap, because replacement of the central thymine with a guanine did not abolish protein-DNA-interaction in vitro. In contrast, substitution of the thymine for an adenine, creating a CACCC-motif, which is a regulatory element in a number of erythroid-speci®c promoters (e.g. Hartzog and Myers, 1993), reduced but not completely prevented binding. The GC-box binding transcription factor Sp1 is unlikely to account for the CT-box binding activity as Sp1 is known to bind GC-boxes and GT-boxes (5'-GGTGGG-3') but not CT-boxes (5'-GGAGGG-3'; e.g. Hagen et al., 1992) . A recent analysis of the human tissue-type plasminogen activator gene by in-vivo-footprinting revealed protein binding to two GC-boxes and one CT-box, but supershift assays with a speci®c antibody detected Sp1 only in complex with the two GC-boxes, the CTbox probe being bound by a dierent, as yet unidenti®ed protein (Arts et al., 1997) .
The presence of a CT-box in close proximity to an E2F-site is similar to the arrangement of the ME1a1-site and the E2F-site in the c-myc promoter (Plet et al., 1992) which is unexpected considering the very dierent spatio-temporal expression patterns of c-myc and N-myc. Since E2F-sites cooperate with dierent nearby cis-elements in several promoters (Karlseder et al., 1996; Liu et al., 1996; Bennet et al., 1996) there In vivo regulation of N-myc expression W Lutz and M Schwab may be cooperation between the CT-box and the ME1a1-site, respectively, and their neighbouring E2F-sites. Such an interaction may serve a regulatory goal that both genes have in common despite their dierent expression pro®les, perhaps in cell cycle regulated expression. A similar arrangement of an E2F-site and a CT-box, which has not been implicated in gene regulation however, is present in the promoter of the cyclin D1 gene (Phillip et al., 1994) .
The same protein DNA interactions regulate N-myc expression in neuroblastomas with ampli®ed and single copy N-myc
All neuroblastoma cell lines with N-myc expression, both with and without ampli®cation, displayed the same changes in promoter architecture represented by the hypersensitive guanines 7159 and 7140, indicating that N-myc expression has a common mechanistic basis in neuroblastomas irrespective of N-myc copy number. A similar conclusion has been reached for the c-erbB-2 gene that can be overexpressed from non ampli®ed as well as ampli®ed genes in mammary tumor cell lines (Hollywood and Hurst, 1993) . In the case of c-erbB-2 binding of a transcription factor to the c-erbB-2 promoter, which was recently identi®ed as AP2, is responsible for overexpression in cell lines both with and without gene ampli®cation (Bosher et al., 1996) . The identi®cation of control elements that contribute to N-myc expression in vivo provides the basis for a more detailed understanding of N-myc regulation in neuroblastomas. Future studies will be directed towards characterizing the proteins that bind to these elements. From this we expect an explanation both for the failure of cells to down-regulate N-myc during neuroblastoma tumorigenesis and for the neuropreferential expression of N-myc.
Materials and methods
Plasmid construction and site-directed mutagenesis
All luciferase reporter constructs are based on the plasmid pGL3-Basic (Promega). Plasmid pNmyc contains a 242 bp N-myc promoter fragment that was generated by PCR using the primers 5'-CAGCTTTGCAGCCTTCTCT-3' and 5'-GTCCAGACAGATGACTGT-3', and inserted into the SmaI-site of the pGL3-Basic. Plasmid pDKS is derived from pNmyc by removing a KpnI ± SmaI-fragment followed by removal of overhangs with mung bean nuclease and religation leaving behind N-myc promoter sequences from positions 757 to +21. To construct plasmids pDKSx4CT and pDKSx4CTmut the doublestranded EMSA-probes with the CT-box and mutant CT-box (see Figure 4a ), which contain¯anking restriction sites for the enzymes BglII and BamHI, were concatemerized in head to tail orientation as described in (Rosenfeld and Kelly, 1986) . Fragments containing four repeats of the wildtype or mutant CT-box, respectively, were inserted into the BglII and BamHI sites of the multiple cloning site of plasmid pSL1180 (Pharmacia), subsequently cut out with the enzymes SmaI and KpnI, and inserted into pDKS.
Point mutations were introduced into pNmyc by overlapextension-PCR as described (Ho et al., 1989) using the primer combinations listed in Table 2 (mutated bases are typed in italics) with primers RVprimer3 and GLprimer2 (Promega) being used as¯anking primers. After overlap-extension PCR the products were cut with MluI and BglII and inserted into the corresponding sites of pGL3-Basic. All reporter constructs were sequenced on an ABI310 using dye terminator chemistry following the protocoll of the supplier (Perkin Elmer). Construct pE2Fmut contains an additional point mutation outside the E2F-site that was generated during PCR interrupting a stretch of ®ve T residues downstream of the CT-box. Using a second pE2Fmut construct with a spontaneous mutation at a dierent position this mutation was shown not to in¯uence reporter gene expression in transient assays (data not shown).
Plasmids pNmyc3 and pCTmut3 that contain additional sequences of the N-myc gene extending downstream to a XhoI-site in exon 2 were constructed as follows: pNmyc and pCTmut were cut with XhoI and SmaI removing the 3' portion of the 242 bp N-myc sequence but retaining the CTbox and the mutant CT-box, respectively. An EcoRI/XhoIfragment derived from the genomic N-myc clone pNb1 (Amler and Schwab, 1989 ) and a SmaI/EcoRI-fragment from an EcoRI/partial SmaI-digest of the genomic N-myc clone pNb5 (Amler and Schwab, 1989) were simultaneously ligated into either plasmid. Correct assembly of the three DNA-fragments was checked by sequencing into the pNb1-derived and pNb5-derived portions of each clone with anking primers. Expression plasmids for DP1, E2F-1, E2F-3 and E2F-4 (Helin et al., 1992; Beijersbergen et al., 1994; Bandara et al., 1994; Lees et al., 1993) have been described.
Cell culture, transfections and reporter gene assays
All cell lines were grown in RPMI1640 supplemented with 10% FCS, 4 mM L-glutamine, 100 U per ml penicillin, 100 mg per ml streptomycin and 0.5 mg per ml amphotericin. References to the human neuroblastoma cell lines can be found in Schwab, 1985 . Nb-1 and Nb-12 are a kind gift of S Nooner and DN Shapiro. Nb-1 cells do not have Nmyc ampli®cation but Western-blotting revealed high levels of N-Myc protein (data not shown). Nb-12 was originally published as a cell line without N-myc ampli®cation (Shapiro et al., 1993) but the cells we obtained carry ampli®ed N-myc, as demonstrated by FISH-analysis, and show strong N-myc expression (data not shown).
All cell lines were transfected in 12-well-microtiterplates using the transfection reagent DOTAP (Boehringer, Mannheim) as described (Lutz et al., 1996) . pCMVbgal was cotransfected to control for dierences in transfection eciency. In the transient co-transfection experiments 0.5 mg luciferase reporter construct, 0.5 mg of each DP1 and E2F expression vector and 0.25 mg pCMVbgal were used per well. Cells were 
DMS-in-vivo-footprinting
The genomic footprint analysis was performed by ligation-mediated PCR (LM ± PCR; Mueller and Wold, 1989) based on a`Linker Tag Selection' procedure that involves a biotinylated linker primer and paramagnetic streptavidin-coated beads (Dynal) following the protocol of Quivy and Becker (1993) with some modi®cations. Brie¯y, cells were treated with cell culture medium containing 0.2% DMS (Fluka) at room temperature for 5 min. After washing the cells twice in ice-cold PBS the modi®ed genomic DNA was isolated and extracted two times with phenol. After ethanol precipitation lyophilized DNA was cleaved at methylated guanine residues with 1 M piperidine (Sigma) for 30 min at 908C. Control samples of naked genomic DNA were produced by standard Maxam-Gilbert chemistry. 300 ng of nicked DNA were used for the ®rst linear extension. After linker ligation 20 PCR cycles were performed with DNA from cell lines without N-myc ampli®cation and 14 cycles were performed with DNA from cell lines with ampli®cation resulting in equal signal strength for all samples in the autoradiograph. The smaller number of PCR cycles with DNA from cell lines with N-myc ampli®cation was calculated as follows: 100 to 150 copies of ampli®ed N-myc per diploid genome are equivalent to roughly six cycles of exponential amplification (two template molecules ?4?8?16?32?64?128 copies) . Equal signal strength of individual bands will only result, however, if the relative sensitivity of a particular guanine towards methylation by DMS in vivo is similar in ampli®ed and single copy N-myc. If, for example, only two of the 100 copies of guanine 7159 were hypersensitive in Kelly cells then the intensity of the corresponding autoradiographic band would be expected to be weaker in Kelly than in Nb-1. For linear extensions with primers 1 and 3 Vent (exo-) DNA polymerase (New England Biolabs) was used while the PCR was performed with standard Taq-polymerase. For the ®nal linear extension step with 32 P-labeled primer 3 seven extension cycles were performed instead of one to increase sensitivity. The sequences of the linker oligonucleotides have been described (Mueller and Wold, 1989) . The longer primer was biotinylated at the 5' end. The other primers used are listed in Table 3 . Primer sets B and BX were used for footprinting the promoter of the human N-myc gene (see Figure 1a ). Primer set A was used for footprinting the promoter of the human aldolase C gene to control for the quality of nicked DNA. It covers a region of the aldolase C gene starting from position+27 relative to the transcription start site to 7150 that was previously shown by in vitrofootprinting experiments to span three closely spaced regulatory elements (called footprints A, B, and C; Buono et al., 1993) . All DNA preparations used for LM ± PCR with N-myc-speci®c primer sets showed at least 50% protection of the aldolase C promoter region containing footprint B when tested in LM ± PCR with primer set A (data not shown).
Preparation of nuclear extracts and electrophoretic mobility shift assay Nuclear extracts were prepared by the`mini-extract' procedure (Schreiber et al., 1989) . Protein concentrations were determined using the Protein Assay Kit from BioRad. Probes for electrophoretic mobility shift assay were generated by ®ll in of protruding 5' termini of annealed complementary oligonucleotides with Klenow polymerase in the presence of [a- 32 P]dCTP. The oligonucleotides used to generate the wild-type probe have the sequence 5'-GATCTTGGCGCCTCCCCTGATTTTTATGGAAG-3' and 5'-GATCCTTCCATAAAAATCAGGGGAGGCGC-CAA-3'. Mutant competitors were produced using oligonucleotides with the sequence changes listed in Figure 4b . A 20 ml binding reaction contained 25 000 c.p.m. of probe (5 ± 25 fMol), which had been puri®ed by electrophoresis through a 10% polyacrylamidgel under native conditions, 5 mg of nuclear extract, 20 mM HEPES (pH 7.9), 1 mM DTT, 50 mM KCl, 10 mM MgCl 2 , 10% Glycerol and 2 mg poly(dIdC) as a non speci®c competitor. Speci®c competitors, Zn 2 SO 4 and 1,10-orthophenanthroline were added as indicated before addition of the radiolabeled probe. After incubation at room temperature for 15 min the samples were loaded on a 5% polyacrylamid gel. Electrophoresis was carried out in high ionic strength Tris-glycine buer at 48C.
Note added in proof While this manuscript was under review Cohen et al. reported that a CT-box in the wt1 gene binds Sp1 (J. Biol. Chem., 272, 2901 Chem., 272, ± 2913 . The CT-box in wt1 shows an extended homology of 11 out of 13 bps to the N-myc gene around the CT-box (among the homologous bases are those that are mutated in competitor probe mut0 in Figure  4 ). In the meantime we could show that an Sp1 speci®c antibody supershifts the CT-box/CT-box binding protein In vivo regulation of N-myc expressioncomplex (shift A) demonstrating that Sp1 is the protein binding to the N-myc CT-box in vitro.
